Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know
Non-valvular AF is a common clinical condition associated with an increased risk of thromboembolic complications. As a consequence, oral anticoagulant therapy (OAT) is the cornerstone of non-valvular AF management. Despite the well-established efficacy of OAT, many patients cannot receive this preve...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2023-09-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2023.18 |
| _version_ | 1826933134027915264 |
|---|---|
| author | Pierluigi Merella Giuseppe Talanas Giovanni Lorenzoni Cristiana Denurra Enrico Atzori Gavino Casu |
| author_facet | Pierluigi Merella Giuseppe Talanas Giovanni Lorenzoni Cristiana Denurra Enrico Atzori Gavino Casu |
| author_sort | Pierluigi Merella |
| collection | DOAJ |
| description | Non-valvular AF is a common clinical condition associated with an increased risk of thromboembolic complications. As a consequence, oral anticoagulant therapy (OAT) is the cornerstone of non-valvular AF management. Despite the well-established efficacy of OAT, many patients cannot receive this preventive therapy due to bleeding or a high risk of bleeding. The fact that more than 90% of thrombi are formed in the left atrial appendage has led to the development of alternative methods to reduce the embolic risk. Left atrial appendage occlusion (LAAO) is a non-pharmacological option for preventing cardioembolic events in patients with non-valvular AF with a contraindication to OAT. The demand for LAAO procedures is growing exponentially and clinicians should consider this alternative option when managing patients with a contraindication to OAT. This review summarises the current thinking about LAAO. |
| first_indexed | 2024-03-07T17:39:03Z |
| format | Article |
| id | doaj.art-766d749ed896474594152712dcf945b3 |
| institution | Directory Open Access Journal |
| issn | 1758-3756 1758-3764 |
| language | English |
| last_indexed | 2025-02-17T17:27:11Z |
| publishDate | 2023-09-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | European Cardiology Review |
| spelling | doaj.art-766d749ed896474594152712dcf945b32024-12-14T16:04:42ZengRadcliffe Medical MediaEuropean Cardiology Review1758-37561758-37642023-09-011810.15420/ecr.2023.18Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should KnowPierluigi Merella0Giuseppe Talanas1Giovanni Lorenzoni2Cristiana Denurra3Enrico Atzori4Gavino Casu5Department of Cardiology, Azienda Ospedaliero Universitaria di Sassari, Sassari, ItalyDepartment of Cardiology, Azienda Ospedaliero Universitaria di Sassari, Sassari, ItalyDepartment of Cardiology, Azienda Ospedaliero Universitaria di Sassari, Sassari, ItalyDepartment of Cardiology, Azienda Ospedaliero Universitaria di Sassari, Sassari, ItalyDepartment of Cardiology, Azienda Ospedaliero Universitaria di Sassari, Sassari, ItalyDepartment of Cardiology, Azienda Ospedaliero Universitaria di Sassari, Sassari, ItalyNon-valvular AF is a common clinical condition associated with an increased risk of thromboembolic complications. As a consequence, oral anticoagulant therapy (OAT) is the cornerstone of non-valvular AF management. Despite the well-established efficacy of OAT, many patients cannot receive this preventive therapy due to bleeding or a high risk of bleeding. The fact that more than 90% of thrombi are formed in the left atrial appendage has led to the development of alternative methods to reduce the embolic risk. Left atrial appendage occlusion (LAAO) is a non-pharmacological option for preventing cardioembolic events in patients with non-valvular AF with a contraindication to OAT. The demand for LAAO procedures is growing exponentially and clinicians should consider this alternative option when managing patients with a contraindication to OAT. This review summarises the current thinking about LAAO.https://www.ecrjournal.com/articleindex/ecr.2023.18 |
| spellingShingle | Pierluigi Merella Giuseppe Talanas Giovanni Lorenzoni Cristiana Denurra Enrico Atzori Gavino Casu Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know European Cardiology Review |
| title | Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know |
| title_full | Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know |
| title_fullStr | Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know |
| title_full_unstemmed | Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know |
| title_short | Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know |
| title_sort | percutaneous left atrial appendage occlusion what the practising physician should know |
| url | https://www.ecrjournal.com/articleindex/ecr.2023.18 |
| work_keys_str_mv | AT pierluigimerella percutaneousleftatrialappendageocclusionwhatthepractisingphysicianshouldknow AT giuseppetalanas percutaneousleftatrialappendageocclusionwhatthepractisingphysicianshouldknow AT giovannilorenzoni percutaneousleftatrialappendageocclusionwhatthepractisingphysicianshouldknow AT cristianadenurra percutaneousleftatrialappendageocclusionwhatthepractisingphysicianshouldknow AT enricoatzori percutaneousleftatrialappendageocclusionwhatthepractisingphysicianshouldknow AT gavinocasu percutaneousleftatrialappendageocclusionwhatthepractisingphysicianshouldknow |